2023-04-11 16:52:31 ET
- PLx Pharma ( NASDAQ: PLXP ) was notified by the Listing Qualifications Department to delist the Co.’s securities from Nasdaq , citing that for a period of 30 consecutive business days, the bid price of its common stock had closed below the minimum of $1/share.
- In accordance with Nasdaq Listing Rule, the Co. was provided 180 calendar days, or until April 3, 2023, to regain compliance with the minimum bid requirement.
- The Co. does not intend to appeal Nasdaq’s determination and, therefore, it is expected that the Co.’s common stock will be delisted from the Nasdaq on April 13, 2023.
For further details see:
PLx Pharma to be delisted from the Nasdaq on April 13